SSII
SS Innovations International, Inc.
$3.60
+0.02 (+0.56%)
At close · Jul 8
Market Cap
$720.47M
Shares
200,131,535
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.60
Open$3.53
Day$3.51–3.77
52W$3.11–10.00
Avg vol 30d66K
Short int53K · 0.0% float · 1.0d
Short vol55%
Last earningsMay 13, 2026
DataAug 2024–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−32%
below
Price vs 50-day avg
−6%
below
RSI (14)
48
neutral
MACD trend
Positive
52-week position
7%
near low
Momentum
relative strength
1-month return
+2%
trailing
6-month return
−39%
trailing
YTD return
−37%
this year
Relative strength
−47%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
+8% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +3.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
26 holders — near 1-yr high, broad support
Squeeze score
24
low risk · 0–100
Fundamentals
Revenue growth
+106%
Y/Y
Gross margin
46%
expanding
EPS growth
+45%
Y/Y
Free cash flow
$-22.2M
Balance sheet
$2.7M
net cash
Quant / Vol
risk profile
Volatility
105%
annualized · 1-yr
Max drawdown
−67%
past year
ATR
9.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 5, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−32%
Bearish
Price vs 50-day avg
−6%
Bearish
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
7%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
+8% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +3.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
26 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $3
Now $4 · 7%
52-wk high $10
vs 200-day avg -32%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cumulative cardiac procedures | 482 | Q1 2026 | — |
| Cumulative pediatric surgeries | 161 | Q1 2026 | — |
| Cumulative telesurgeries | 157 | Q1 2026 | — |
| SSi Mantra surgeries | 1,859 | Q1 2026 | — |
|
|
|||
| Cardiac procedures (cumulative) | 390 | As of December 31, 2025 | — |
| Cumulative surgeries | 7,885 | As of December 31, 2025 | — |
| Pediatric surgeries (cumulative) | 121 | As of December 31, 2025 | — |
| SSi Mantra cumulative installed base | 168 | As of December 31, 2025 | — |
| SSi Mantra surgical robotic system installations | 103 | Full Year 2025 | — |
| Telesurgeries (cumulative) | 120 | As of December 31, 2025 | — |
| SSi Mantra installations | 103 | full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SSII
this stock
SS Innovations International, Inc.
|
$720.47M | -36.6% | +105.7% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$165.79B | -23.6% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.30B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$104.98B | -13.9% | +8.4% | 22.0 | 1.4% |
|
BSX
Boston Scientific Corp
|
$66.60B | -53.0% | +5.5% | 18.8 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SSII | -13.3% | +2.0% | -39.3% | -13.3% | -36.6% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -13.1% | +1.1% | -46.7% | -13.1% | -45.9% |